Clinical Trial Update: High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing high dose versus low dose Iodine-131 with or without rhTSH in differentiated thyroid cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer
• Head and Neck Cancer

Drugs mentioned

• Iodine-131 (Iodine-131)
• rhTSH (recombinant human thyroid-stimulating hormone)

Snippet

Sponsor: University College, London | Conditions: Head and Neck Cancer | Phase 3 | Status: UNKNOWN